Candesartan HCT Actavis

Medicinal product

(Invented) name

Candesartan HCT Actavis

Active substance (s)

Kandesartano cileksetilas/Hidrochlorotiazidas

Strength

32 mg/12,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DA06, Candesartan and diuretics

Marketing authorisation holder

UAB Actiofarma, Lietuva

Date of authorisation

2020-08-13

Date of renewal

Documents

1377-001_Candesartan HCT Actavis_2020-09-30.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Kandesartano cileksetilas	32 mg
Hidrochlorotiazidas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104891	90992	1090992	lizdinė plokštelė	N30		Receptinis	LT/L/20/1377/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2020-08-13	Registruotas